Edgestream Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$292K Buy
+5,588
New +$335K 0.01% 806
2025
Q3
Sell
-229,625
Closed -$11.8M 1053
2025
Q2
$11.8M Buy
229,625
+31,586
+16% +$1.59M 0.33% 40
2025
Q1
$11.6M Buy
198,039
+184,703
+1,385% +$12.5M 0.39% 22
2024
Q4
$961K Buy
+13,336
New +$979K 0.04% 579
2024
Q3
Sell
-36,956
Closed -$2.65M 1079
2024
Q2
$2.65M Sell
36,956
-20,591
-36% -$1.52M 0.13% 260
2024
Q1
$4.05M Buy
+57,547
New +$4.12M 0.2% 166
2023
Q4
Sell
-11,745
Closed -$799K 1059
2023
Q3
$799K Buy
+11,745
New +$928K 0.06% 464
2023
Q2
Sell
-18,173
Closed -$1.35M 910
2023
Q1
$1.35M Buy
+18,173
New +$1.4M 0.15% 223
2022
Q4
Sell
-44,132
Closed -$3.13M 635
2022
Q3
$3.13M Buy
+44,132
New +$3.81M 0.24% 145
2022
Q1
Sell
-20,508
Closed -$2.65M 632
2021
Q4
$2.65M Sell
20,508
-24,396
-54% -$2.99M 0.17% 186
2021
Q3
$5.44M Sell
44,904
-23,776
-35% -$2.89M 0.34% 91
2021
Q2
$7.73M Buy
+68,680
New +$7.23M 0.46% 69

Other funds holding TECH

Edgestream Partners's TECH Position: Q1 2026 in Review

Edgestream Partners opened a new position in Bio-Techne (TECH) in Q1 2026: 5,588 shares worth $292K. The stake represents 0.01% of the portfolio and ranks #806 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in TECH as recently as Q2 2025.

Edgestream Partners first reported a position in TECH in Q2 2021 and has held it in 12 quarters since. The position peaked at $11.8M in Q2 2025. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Edgestream Partners held 5,588 shares of Bio-Techne worth $292K as of Q1 2026.
  • Bio-Techne was a new Edgestream Partners position in Q1 2026.
  • Bio-Techne made up 0.01% of Edgestream Partners's portfolio in Q1 2026, its #806 holding.
  • Edgestream Partners first reported a position in Bio-Techne in Q2 2021 and has held it in 12 quarters since.
  • Edgestream Partners's Bio-Techne position peaked at $11.8M in Q2 2025.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.